Mr. McComas brings 25 years of investment banking experience in M&A, debt and equity funding across multiple industry sectors. He previously held senior leadership roles with Grant Samuel, County NatWest (now Citigroup) and Morgan Grenfell (now Deutsche Bank) in Australia and the UK. Prior to this, he was a tax lawyer.
Mr. McComas is also an experienced company director and currently serves as Chairman of Pharmaxis (ASX: PXS) and Fitzroy River Corporation (ASX:FZR) and as a director of Core Lithium (ASX: CXO). He was previously a director of BCI Minerals (ASX:BCI), Saunders International (ASX: SND) and other entities.
Mr. McComas is also a director the Australasian Leukemia and Lymphoma clinical trials group (ALLG) and a former president of the Financial Services Institute of Australia (FINSIA). He is a Fellow of the Australian Institute of Company Directors and holds degrees in Law and Economics from Monash University in Melbourne.
LinkedIn Profile: https://www.linkedin.com/in/malcolmmccomas